This inventor holds 2 USPTO granted patents. Top assignee: Tongji University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Fulei Zhang: Innovator in Cardiac Treatment
Introduction
Fulei Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of heart diseases. His innovative work focuses on the use of heterocyclic derivatives that promote cardiomyocyte proliferation.
Latest Patents
Fulei Zhang holds a patent for the "Use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases." This patent outlines the application of specific compounds that can aid in the treatment of heart conditions. The compounds described in the patent include various forms such as salts, solvates, stereoisomers, or prodrugs, which are detailed in the specification.
Career Highlights
Zhang is affiliated with Tongji University, where he conducts research and develops his innovative ideas. His work has garnered attention for its potential impact on cardiac health and treatment methodologies.
Collaborations
Zhang collaborates with notable colleagues, including Yihan Chen and Dandan Liang, who contribute to his research efforts and advancements in the field.
Conclusion
Fulei Zhang's contributions to cardiac treatment through his innovative patent highlight the importance of research in improving health outcomes. His work exemplifies the potential of scientific advancements in addressing critical health issues.